TrialJournal of clinical lipidology

Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087.

Carl J Fichtenbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.